These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 3729480)
1. [Chemotherapy in the multi-disciplinary treatment of head and neck tumors: evaluation of a chemosensitivity test]. Saito H Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1744-52. PubMed ID: 3729480 [TBL] [Abstract][Full Text] [Related]
2. [Chemosensitivity of human head and neck tumors detected by human tumor clonogenic assay]. Suzuki K; Fujii M; Ishii Y; Mochizuki F; Suzuki K; Yamagata M; Suzuki H; Moriya Y; Abiko Y; Sakabe T Nichidai Koko Kagaku; 1989 Jun; 15(2):153-6. PubMed ID: 2483253 [TBL] [Abstract][Full Text] [Related]
3. [Studies on a neo-adjuvant chemotherapy for head and neck cancer]. Inuyama Y; Mashino S; Fujii M; Tanaka J; Takaoka T; Kohno N; Horiuchi M Gan To Kagaku Ryoho; 1983 Mar; 10(3):786-91. PubMed ID: 6192768 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of optimal drug concentration in histoculture drug response assay in association with clinical efficacy for head and neck cancer. Hasegawa Y; Goto M; Hanai N; Ijichi K; Adachi M; Terada A; Hyodo I; Ogawa T; Furukawa T Oral Oncol; 2007 Sep; 43(8):749-56. PubMed ID: 17112769 [TBL] [Abstract][Full Text] [Related]
5. [Human tumor clonogenic assay in human breast cancer]. Kobayashi T; Kuraishi Y; Aiba K; Inoue K Gan To Kagaku Ryoho; 1985 Aug; 12(8):1566-72. PubMed ID: 3927846 [TBL] [Abstract][Full Text] [Related]
6. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck. Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121 [TBL] [Abstract][Full Text] [Related]
7. [Role of Chemotherapy in head and neck cancer]. Kohno N; Kitahara S Gan To Kagaku Ryoho; 2001 Apr; 28(4):448-53. PubMed ID: 11329777 [TBL] [Abstract][Full Text] [Related]
8. [Update of human tumor clonogenic assay in carcinoma of the lung]. Kanzawa F Gan To Kagaku Ryoho; 1985 Aug; 12(8):1552-9. PubMed ID: 2992395 [TBL] [Abstract][Full Text] [Related]
9. Polymer chemotherapy for head and neck cancer. Shikani AH; Domb AJ Laryngoscope; 2000 Jun; 110(6):907-17. PubMed ID: 10852503 [TBL] [Abstract][Full Text] [Related]
10. Systemic chemotherapy with cisplatin plus 5-FU (PF) for recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): efficacy and safety of a lower dose of PF (80/800) at a single institution in Japan. Kiyota N; Tahara M; Kadowaki S; Fuse N; Doi T; Minami H; Ohtsu A Jpn J Clin Oncol; 2009 Apr; 39(4):225-30. PubMed ID: 19211574 [TBL] [Abstract][Full Text] [Related]
11. Long-term neck control rates after complete response to chemoradiation in patients with advanced head and neck cancer. Rengan R; Pfister DG; Lee NY; Kraus DH; Shah JP; Shaha AR; Ben-Porat LS; Zelefsky MJ Am J Clin Oncol; 2008 Oct; 31(5):465-9. PubMed ID: 18838883 [TBL] [Abstract][Full Text] [Related]
12. Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience. Papadimitrakopoulou VA; Dimery IW; Lee JJ; Perez C; Hong WK; Lippman SM Cancer J Sci Am; 1997; 3(2):92-9. PubMed ID: 9099459 [TBL] [Abstract][Full Text] [Related]
13. [Combination chemotherapy with 5-FU and CDDP or CDDP analog for head and neck cancer]. Fujii M; Ohno Y; Tokumaru Y; Imanishi Y; Kanke M Gan To Kagaku Ryoho; 1996 Nov; 23(13):1740-6. PubMed ID: 8937483 [TBL] [Abstract][Full Text] [Related]
14. Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors. Cullen KJ; Newkirk KA; Schumaker LM; Aldosari N; Rone JD; Haddad BR Cancer Res; 2003 Dec; 63(23):8097-102. PubMed ID: 14678959 [TBL] [Abstract][Full Text] [Related]
15. [Bladder cancer: chemotherapy of advanced bladder cancer]. Koiso K Gan To Kagaku Ryoho; 1982 Mar; 9(3):377-86. PubMed ID: 6820897 [TBL] [Abstract][Full Text] [Related]
16. [The effect of the microenvironment of head and neck cancers on tumor progression]. Lukits J Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327 [TBL] [Abstract][Full Text] [Related]
17. [Head and neck cancer]. Inuyama Y; Fukuda S; Fujii M; Tanaka K; Kawaura M; Kawasaki K; Kohno N Gan To Kagaku Ryoho; 1996 Aug; 23(9):1136-42. PubMed ID: 8751800 [TBL] [Abstract][Full Text] [Related]
18. Recent advances in paclitaxel-containing chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck. Shin DM; Glisson BS; Khuri FR; Ginsberg L; Lawhorn K; Hong WK; Lippman SM Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-33-S19-37. PubMed ID: 9427263 [TBL] [Abstract][Full Text] [Related]
19. Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: mature results from a single institution. Adelstein DJ; Saxton JP; Rybicki LA; Esclamado RM; Wood BG; Strome M; Lavertu P; Lorenz RR; Carroll MA J Clin Oncol; 2006 Mar; 24(7):1064-71. PubMed ID: 16505425 [TBL] [Abstract][Full Text] [Related]
20. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up. Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]